Early Response of Prostate Carcinoma Xenografts to Docetaxel Chemotherapy Monitored With Diffusion MRI
Open Access
- 1 January 2002
- Vol. 4 (3) , 255-262
- https://doi.org/10.1038/sj.neo.7900225
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging.2001
- T1ρ Imaging of Murine Brain Tumors at 4 TAcademic Radiology, 2001
- Acute Metabolic Alkalosis Enhances Response of C3H Mouse Mammary Tumors to the Weak Base MitoxantroneNeoplasia, 2001
- Diffusion Magnetic Resonance Imaging: an Early Surrogate Marker of Therapeutic Efficacy in Brain TumorsJNCI Journal of the National Cancer Institute, 2000
- Magnetic Resonance Imaging to Measure Therapeutic Response Using an Orthotopic Model of Human Pancreatic CancerPancreas, 2000
- OPTIMAL PREDICTORS OF PROSTATE CANCER ON REPEAT PROSTATE BIOPSY: A PROSPECTIVE STUDY OF 1,051 MENJournal of Urology, 2000
- Applications of Magnetic Resonance in Model Systems: Cancer TherapeuticsNeoplasia, 2000
- Applications of Magnetic Resonance in Model Systems: Tumor Biology and PhysiologyNeoplasia, 2000
- DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.1999
- Early Increases in Breast Tumor Xenograft Water Mobility in Response to Paclitaxel Therapy Detected by Non-Invasive Diffusion Magnetic Resonance ImagingNeoplasia, 1999